VistaGen Therapeutics
VTGN
#9358
Rank
โ‚ฌ56.35 M
Marketcap
1,95ย โ‚ฌ
Share price
-5.13%
Change (1 day)
-55.42%
Change (1 year)

Earnings for VistaGen Therapeutics (VTGN)

Earnings in 2024 (TTM): -โ‚ฌ49.11 Million

According to VistaGen Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ0.69 Million. a decrease over its 2023 earnings that were of -โ‚ฌ29.81 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for VistaGen Therapeutics from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ46.48 Million55.93%
2023 -โ‚ฌ29.81 Million-46.81%
2022 -โ‚ฌ56.04 Million70.9%
2021 -โ‚ฌ32.8 Million149.03%
2020 -โ‚ฌ13.17 Million-39.09%
2019 -โ‚ฌ21.62 Million7.16%
2018 -โ‚ฌ20.18 Million34.78%
2017 -โ‚ฌ14.97 Million7.87%
2016 -โ‚ฌ13.88 Million-62.22%
2015 -โ‚ฌ36.73 Million518.34%
2014 -โ‚ฌ5.94 Million-4.87%
2013 -โ‚ฌ6.25 Million-36.51%
2012 -โ‚ฌ9.84 Million48.41%
2011 -โ‚ฌ6.63 Million84117.81%
2010 -โ‚ฌ0.01 Million-59.28%
2009 -โ‚ฌ0.02 Million34.07%
2008 -โ‚ฌ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.13 Billion 170.44%๐Ÿ‡บ๐Ÿ‡ธ USA